Learn More
Medchemexpress LLC 2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-(3,4-dihydroxyphenyl)ethanone hydrochloride | 1036069-26-7 | MFCD11114394 | 99.4% | 269.34 g/mol | C11H11NO3S2 | 5 MG

Supplier: Medchemexpress LLC HY1086365MG
RETRA is a small-molecule research compound that acts as a mutant p53-dependent activator of p73, increasing p73 expression and releasing p73 from inhibitory complexes to produce tumor-suppressor effects. It is supplied as a solid for laboratory use (CAS 1036069-26-7; molecular weight 269.34 g/mol).
- Mutant p53-dependent activator of p73.
- Increases p73 expression and releases it from inhibitory complexes.
- High reported purity suitable for research (99.4%).
- Supplied in small research pack sizes, including 5 mg.
- Store at -20°C and protect from light; in solvent store at -80°C for long-term.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.